Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 83601-83650 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05522972
Establishing New Treatment Approaches for Amblyopia: Perceptual Learning and Video Games
NARecruiting
180 participants
Started: Sep 13, 2022 · Completed: Aug 31, 2029
1 condition1 sponsor1 location
NCT05450679
Cervical Paraspinal Muscle Twitching and Cervical Facet Radiofrequency Ablation Outcomes
N/AActive, not recruiting
60 participants
Started: Sep 13, 2022 · Completed: Aug 1, 2027
3 conditions1 sponsor1 location
NCT05528510
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
PHASE3Active, not recruiting
418 participants
Started: Sep 13, 2022 · Completed: Oct 6, 2028
1 condition1 sponsor235 locations
NCT05467891
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer
PHASE2Recruiting
200 participants
Started: Sep 13, 2022 · Completed: Aug 31, 2029
3 conditions2 sponsors18 locations
NCT04796545
Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration
NARecruiting
76 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2028
2 conditions1 sponsor8 locations
NCT05554588
Intrathrombus Thrombolysis Versus Aspiration Thrombectomy During Primary PCI
NARecruiting
2,500 participants
Started: Sep 13, 2022 · Completed: Sep 1, 2026
3 conditions1 sponsor1 location
NCT05401097
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)
PHASE2Recruiting
125 participants
Started: Sep 13, 2022 · Completed: Jun 30, 2029
1 condition2 sponsors1 location
NCT06581887
Defining Outcome Measures for Behavioural and Emotional Problems in Dystrophinopathies
N/ARecruiting
100 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT05537467
Effect of Music on Cardiopulmonary Exercise Capacity in Heart Failure Patients
NARecruiting
40 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05336812
Acalabrutinib in Combination With Venetoclax or Obinutuzumab for the Treatment of Treatment-naive Chronic Lymphocytic Leukemia
PHASE2Recruiting
52 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05625828
Evaluation of the Effects of a Cognitive-Motor Fall Prevention Program on Fall Risk Factors
NAActive, not recruiting
176 participants
Started: Sep 13, 2022 · Completed: Oct 24, 2025
3 conditions3 sponsors1 location
NCT05435014
T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma
PHASE1/PHASE2Recruiting
90 participants
Started: Sep 13, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor4 locations
NCT05512481
Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma
PHASE2Recruiting
60 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2026
7 conditions1 sponsor1 location
NCT05480800
A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever
PHASE1/PHASE2Recruiting
155 participants
Started: Sep 13, 2022 · Completed: Dec 18, 2024
1 condition5 sponsors2 locations
NCT05335070
Reducing Pain From Wisdom Molar Extractions
PHASE2Recruiting
20 participants
Started: Sep 13, 2022 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05081245
ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
PHASE2Recruiting
150 participants
Started: Sep 13, 2022 · Completed: Nov 30, 2026
1 condition1 sponsor41 locations
NCT05001009
Goals of Care Conversations Study
NAEnrolling by invitation
72 participants
Started: Sep 13, 2022 · Completed: Sep 30, 2025
8 conditions1 sponsor3 locations
NCT05708885
Striated Esophageal Motor Function Modulation in Health and Disease
NARecruiting
557 participants
Started: Sep 13, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05327270
Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant Lesions
PHASE1Active, not recruiting
18 participants
Started: Sep 13, 2022 · Completed: Feb 2, 2027
1 condition1 sponsor1 location
NCT05513586
A Study to Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants
PHASE3Active, not recruiting
15 participants
Started: Sep 13, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor9 locations
NCT07039643
The Pilates Method in the Rehabilitation of Achilles Tendinopathy - A Randomised Controlled Study
NAActive, not recruiting
34 participants
Started: Sep 13, 2022 · Completed: Dec 30, 2025
5 conditions1 sponsor1 location
NCT07103161
Managing Impact-related Leakage During Exercise Using Intravaginal Support
NARecruiting
30 participants
Started: Sep 13, 2022 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05211986
Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.
PHASE1/PHASE2Active, not recruiting
28 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor2 locations
NCT05452005
Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer
PHASE1Recruiting
20 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT05338151
Promoting Alcohol Treatment Engagement Post-hospitalization
NARecruiting
450 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06416332
Development and Testing of a Tele-rehabilitation System for Adult Patients With Knee Osteoarthritis
NAActive, not recruiting
34 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT04628026
Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
PHASE3Recruiting
650 participants
Started: Sep 13, 2022 · Completed: Feb 29, 2032
1 condition2 sponsors90 locations
NCT05437250
National Acalabrutinib Observational Study
N/AActive, not recruiting
350 participants
Started: Sep 13, 2022 · Completed: Nov 15, 2026
1 condition1 sponsor61 locations
NCT05536505
Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC
PHASE2Recruiting
180 participants
Started: Sep 13, 2022 · Completed: Oct 1, 2030
1 condition1 sponsor16 locations
NCT04515459
Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma
PHASE2Recruiting
53 participants
Started: Sep 13, 2022 · Completed: Nov 30, 2029
1 condition1 sponsor1 location
NCT05369273
Addition of Platelet Rich Plasma (PRP) in Microfat Lipofilling (MG) in the Treatment of Cranial Flap Scars: A Randomized, Double-blind, Superiority Study
NARecruiting
22 participants
Started: Sep 13, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05448768
Cognitive Effects and Potential Mechanisms of TBS in Subjects With MCI
NAEnrolling by invitation
80 participants
Started: Sep 13, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05009082
Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer
PHASE3Recruiting
970 participants
Started: Sep 13, 2022 · Completed: Dec 31, 2031
3 conditions2 sponsors65 locations
NCT04778527
A Crossover Adherence and Acceptability Study Assessing a DPP Capsule for HIV and Pregnancy Prevention
NAActive, not recruiting
96 participants
Started: Sep 13, 2022 · Completed: Jan 31, 2024
1 condition1 sponsor1 location
NCT05531565
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
PHASE2/PHASE3Recruiting
474 participants
Started: Sep 13, 2022 · Completed: Dec 14, 2027
2 conditions1 sponsor263 locations
NCT05511285
Improving Sleep and Learning in Rehabilitation After Stroke, Part 2
NARecruiting
100 participants
Started: Sep 13, 2022 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT06030908
Outcome After Surgical Reconstruction of the Achilles Tendon Insertion.
N/AActive, not recruiting
23 participants
Started: Sep 13, 2022 · Completed: Oct 31, 2024
2 conditions1 sponsor1 location
NCT05383079
Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer
PHASE1/PHASE2Active, not recruiting
36 participants
Started: Sep 13, 2022 · Completed: Dec 1, 2026
3 conditions1 sponsor1 location
NCT05603793
YoUng Adolescents' behaViour, musculoskeletAl heAlth, Growth & Nutrition
N/AActive, not recruiting
1,304 participants
Started: Sep 13, 2022 · Completed: Sep 25, 2050
6 conditions1 sponsor1 location
NCT05541432
Finding the Optimal Resistance Training Intensity For Your Bones
NAActive, not recruiting
324 participants
Started: Sep 13, 2022 · Completed: Sep 30, 2026
2 conditions4 sponsors3 locations
NCT05255601
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma
PHASE1/PHASE2Recruiting
68 participants
Started: Sep 13, 2022 · Completed: Jul 5, 2028
2 conditions1 sponsor76 locations
NCT05519696
Together Everyone Achieves More (TEAM) Trial
NARecruiting
360 participants
Started: Sep 12, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05425641
MoST-Influenced Behavioral Intervention for Walking
PHASE2Active, not recruiting
624 participants
Started: Sep 12, 2022 · Completed: Jun 1, 2026
2 conditions3 sponsors1 location
NCT05026541
Resilience to Sleep Deprivation and Changes in Sleep Architecture in Shoonya Meditators
NARecruiting
60 participants
Started: Sep 12, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT05187013
Uncontrolled Hypertension Among the Homeless
NAActive, not recruiting
123 participants
Started: Sep 12, 2022 · Completed: Sep 30, 2025
1 condition3 sponsors1 location
NCT05399992
Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD
N/AActive, not recruiting
855 participants
Started: Sep 12, 2022 · Completed: Aug 5, 2026
2 conditions1 sponsor39 locations
NCT05551559
The Effect of Bariatric Surgery on Hepatic Metabolism in Non-Alcoholic Fatty Liver Disease
NAEnrolling by invitation
180 participants
Started: Sep 12, 2022 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT05517668
Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose
PHASE2Recruiting
40 participants
Started: Sep 12, 2022 · Completed: Nov 30, 2025
7 conditions2 sponsors1 location
NCT05526092
OAT-GUT-BRAIN: Effects of Oats and Rice on Comprehensive Health of Metabolically Challenged Individuals
NAActive, not recruiting
72 participants
Started: Sep 12, 2022 · Completed: Dec 31, 2027
3 conditions2 sponsors2 locations
NCT05326386
Gamification and Medication Adherence (GAME Adherence)
NAActive, not recruiting
84 participants
Started: Sep 12, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location